Monte Rosa Therapeutics (GLUE) Institutional Ownership

$14.30 -0.48 (-3.25%)

As of 08/21/2026 04:00 PM Eastern

Current Institutional Ownership Percentage: 79.96%
Number of Institutional Buyers (last 12 months): 93
Total Institutional Inflows (last 12 months): $439.89M

Number of Institutional Sellers (last 12 months): 35
Total Institutional Outflows (last 12 months): $152.50M

Get GLUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GLUE Institutional Buying and Selling by Quarter

Monte Rosa Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/21/2026	Braidwell LP	2,451,562	$59.33M	2.2%	-23.5%	2.874%
8/20/2026	Montanova Capital LLC	3,549,539	$85.90M	1.4%	-16.0%	4.161%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	65,451	$1.58M	0.0%	+239.5%	0.077%
8/19/2026	Wellington Management Group LLP	207,427	$5.02M	0.0%	+61.1%	0.243%
8/19/2026	Nantahala Capital Management LLC	651,993	$15.78B	0.5%	N/A	0.764%
8/18/2026	Empowered Funds LLC	329,266	$7.97M	0.0%	N/A	0.386%
8/17/2026	Seven Fleet Capital Management LP	16,800	$407K	0.1%	-25.4%	0.020%
8/17/2026	Corient Private Wealth LP	19,120	$463K	0.0%	N/A	0.022%
8/17/2026	Bank of America Corp DE	254,561	$6.16M	0.0%	N/A	0.298%
8/17/2026	Boone Capital Management LLC	615,287	$14.89M	3.5%	N/A	0.721%
Get the Latest News and Ratings for GLUE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/15/2026	Jupiter Topco LLC	1,072,494	$25.97M	0.0%	N/A	1.257%
8/15/2026	J. Goldman & Co LP	15,119	$366K	0.0%	N/A	0.018%
8/14/2026	ADAR1 Capital Management LLC	216,752	$5.25M	0.2%	N/A	0.254%
8/14/2026	Legal & General Group Plc	40,376	$977K	0.0%	N/A	0.047%
8/14/2026	The Manufacturers Life Insurance Company	191,877	$4.64M	0.0%	N/A	0.225%
8/12/2026	Ieq Capital LLC	18,959	$459K	0.0%	N/A	0.022%
8/11/2026	Allworth Financial LP	1,236	$30K	0.0%	N/A	0.001%
8/11/2026	E Fund Management Co. Ltd.	8,285	$200K	0.0%	N/A	0.010%
8/7/2026	BlackRock Inc.	6,843,087	$165.60M	0.0%	N/A	8.100%
8/7/2026	Pallas Capital Advisors LLC	9,138	$221K	0.0%	N/A	0.011%
8/7/2026	Deutsche Bank AG	75,061	$1.82M	0.0%	N/A	0.089%
8/7/2026	Alphabet Inc.	372,474	$9.01M	0.0%	N/A	0.441%
8/7/2026	Wealth Effects LLC	10,099	$244K	0.1%	N/A	0.012%
8/6/2026	Bank of New York Mellon Corp	222,521	$5.39M	0.0%	N/A	0.263%
8/6/2026	State of Wyoming	14,215	$344K	0.0%	N/A	0.017%
6/4/2026	Seven Fleet Capital Management LP	22,530	$371K	0.1%	+463.3%	0.027%
5/19/2026	Bank of America Corp DE	387,542	$6.38M	0.0%	+73.3%	0.459%
5/19/2026	Janus Henderson Group PLC	685,926	$11.29M	0.0%	N/A	0.812%
5/18/2026	Royal Bank of Canada	2,168	$36K	0.0%	-23.1%	0.003%
5/18/2026	Empowered Funds LLC	305,398	$5.02M	0.0%	+9.8%	0.362%
5/18/2026	Exome Asset Management LLC	179,484	$2.95M	1.5%	N/A	0.212%
5/16/2026	The Manufacturers Life Insurance Company	209,801	$3.45M	0.0%	+55.8%	0.248%
5/16/2026	Quantinno Capital Management LP	54,003	$888K	0.0%	+60.8%	0.064%
5/15/2026	Rangeley Capital LLC	27,016	$444K	0.4%	-60.0%	0.032%
5/15/2026	OMERS ADMINISTRATION Corp	27,100	$446K	0.0%	N/A	0.032%
5/14/2026	Renaissance Technologies LLC	379,100	$6.24M	0.0%	N/A	0.449%
5/14/2026	Arrowstreet Capital Limited Partnership	647,739	$10.66M	0.0%	+110.5%	0.767%
5/14/2026	Sei Investments Co.	77,681	$1.28M	0.0%	+30.2%	0.092%
5/14/2026	State of Wyoming	17,645	$290K	0.0%	N/A	0.021%
5/7/2026	Dimensional Fund Advisors LP	1,041,372	$17.13M	0.0%	+83.2%	1.234%
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
5/7/2026	AlphaCentric Advisors LLC	12,566	$207K	0.2%	N/A	0.015%
5/7/2026	Swiss National Bank	61,100	$1.01M	0.0%	N/A	0.072%
5/6/2026	Allspring Global Investments Holdings LLC	392,227	$6.45M	0.0%	+1,355.1%	0.465%
5/5/2026	Versant Venture Management LLC	3,180,780	$52.32M	37.0%	-27.4%	3.770%
5/5/2026	Bank of New York Mellon Corp	204,687	$3.37M	0.0%	+18.1%	0.243%
5/4/2026	Principal Financial Group Inc.	42,391	$697K	0.0%	N/A	0.053%
4/25/2026	Strs Ohio	42,700	$702K	0.0%	+18.3%	0.053%
4/22/2026	Sterling Capital Management LLC	2,005	$33K	0.0%	-78.9%	0.003%
4/16/2026	SG Americas Securities LLC	20,468	$337K	0.0%	+18.5%	0.026%
2/26/2026	Seven Fleet Capital Management LP	4,000	$63K	0.0%	N/A	0.006%
2/23/2026	Virtu Financial LLC	18,717	$293K	0.0%	+56.6%	0.029%
2/19/2026	Invesco Ltd.	362,213	$5.68M	0.0%	+270.0%	0.556%
2/18/2026	Mercer Global Advisors Inc. ADV	10,971	$172K	0.0%	N/A	0.017%
2/18/2026	Empowered Funds LLC	278,077	$4.36M	0.0%	+218.0%	0.427%
2/18/2026	XTX Topco Ltd	31,125	$488K	0.0%	-37.9%	0.048%
2/18/2026	Voloridge Investment Management LLC	35,783	$561K	0.0%	N/A	0.055%
2/18/2026	Vestal Point Capital LP	775,000	$12.15M	0.4%	-3.1%	1.190%
2/18/2026	Virtus Investment Advisers LLC	16,310	$256K	0.1%	-29.5%	0.025%
2/18/2026	Wellington Management Group LLP	148,057	$2.32M	0.0%	-6.6%	0.227%
2/18/2026	Millennium Management LLC	103,972	$1.63M	0.0%	-76.6%	0.160%
2/18/2026	Man Group plc	16,312	$256K	0.0%	-59.8%	0.025%
2/18/2026	Baker BROS. Advisors LP	4,345,736	$68.14M	0.4%	-11.6%	6.673%
2/18/2026	Bridgeway Capital Management LLC	523,377	$8.21M	0.2%	+45.8%	0.804%
2/18/2026	BVF Inc. IL	3,835,886	$60.15M	2.0%	-32.2%	5.890%
2/17/2026	AQR Capital Management LLC	785,057	$12.31M	0.0%	+9.5%	1.206%
2/17/2026	Braidwell LP	948,316	$14.87M	0.5%	N/A	1.456%
2/17/2026	MPM Bioimpact LLC	1,173,376	$18.40M	2.1%	N/A	1.802%
2/17/2026	Trexquant Investment LP	149,712	$2.35M	0.0%	N/A	0.230%
2/17/2026	Price T Rowe Associates Inc. MD	5,118,904	$80.27M	0.0%	+10.4%	7.861%
2/17/2026	Diadema Partners LP	62,281	$977K	0.2%	N/A	0.096%
2/17/2026	Atom Investors LP	137,261	$2.15M	0.2%	N/A	0.211%
2/17/2026	Royal Bank of Canada	2,818	$44K	0.0%	-99.4%	0.004%
2/17/2026	Persistent Asset Partners Ltd	22,211	$348K	0.2%	N/A	0.034%
2/16/2026	Squarepoint Ops LLC	10,029	$157K	0.0%	-89.4%	0.015%
2/16/2026	Mariner LLC	21,600	$340K	0.0%	+56.9%	0.033%
2/16/2026	Barclays PLC	135,984	$2.13M	0.0%	+86.4%	0.209%
2/13/2026	Nantahala Capital Management LLC	57,991	$909K	0.0%	N/A	0.089%
2/13/2026	Marshall Wace LLP	398,890	$6.26M	0.0%	-55.8%	0.613%
2/13/2026	The Manufacturers Life Insurance Company	134,674	$2.15M	0.0%	+13.8%	0.207%
2/13/2026	Advisory Research Inc.	63,220	$991K	0.1%	N/A	0.097%
2/13/2026	Rafferty Asset Management LLC	67,438	$1.06M	0.0%	N/A	0.104%
2/13/2026	Charles Schwab Investment Management Inc.	448,714	$7.04M	0.0%	+17.1%	0.689%
2/13/2026	Police & Firemen s Retirement System of New Jersey	12,417	$195K	0.0%	-22.4%	0.019%
2/13/2026	State Street Corp	2,107,480	$33.05M	0.0%	+148.9%	3.236%
2/13/2026	Ieq Capital LLC	89,268	$1.40M	0.0%	+51.1%	0.137%
2/13/2026	Martingale Asset Management L P	12,413	$195K	0.0%	N/A	0.019%
2/13/2026	Wells Fargo & Company MN	52,588	$825K	0.0%	+45.0%	0.081%
2/13/2026	Alphabet Inc.	744,948	$11.68M	0.5%	-49.1%	1.144%
2/12/2026	Versant Venture Management LLC	4,382,687	$68.72M	45.5%	-22.5%	6.730%
2/12/2026	MetLife Investment Management LLC	26,187	$411K	0.0%	+7.5%	0.040%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
2/12/2026	Dimensional Fund Advisors LP	568,367	$8.91M	0.0%	-10.1%	0.873%
2/12/2026	Informed Momentum Co LLC	70,037	$1.10M	0.1%	N/A	0.108%
2/12/2026	Campbell & CO Investment Adviser LLC	90,752	$1.42M	0.1%	+77.5%	0.139%
2/12/2026	Nuveen LLC	285,859	$4.48M	0.0%	+177.6%	0.439%
2/11/2026	Empowered Funds LLC	278,077	$4.36M	0.0%	+218.0%	0.427%
2/11/2026	Deutsche Bank AG	33,108	$519K	0.0%	+34.7%	0.051%
2/11/2026	Franklin Resources Inc.	85,231	$1.34M	0.0%	+96.3%	0.131%
2/11/2026	Los Angeles Capital Management LLC	26,806	$420K	0.0%	-5.6%	0.041%
2/11/2026	WINTON GROUP Ltd	22,930	$360K	0.0%	N/A	0.035%
2/10/2026	TD Asset Management Inc	213,464	$3.35M	0.0%	+24.1%	0.328%

GLUE Institutional Ownership - Frequently Asked Questions

During the previous two years, 144 institutional investors and hedge funds held shares of Monte Rosa Therapeutics. The most heavily invested institutionals were Nantahala Capital Management LLC ($15.78B), BlackRock Inc. ($165.60M), Montanova Capital LLC ($85.90M), Price T Rowe Associates Inc. MD ($80.27M), Baker BROS. Advisors LP ($68.14M), BVF Inc. IL ($60.15M), and Braidwell LP ($59.33M).Learn more on Monte Rosa Therapeutics' institutional investors.

79.96% of Monte Rosa Therapeutics' stock is owned by institutional investors. Learn more on GLUE's institutional investor holdings.

Of the 129 institutional investors that purchased Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($6.84M), BVF Inc. IL ($5.66M), Versant Venture Management LLC ($5.65M), AQR Capital Management LLC ($1.35M), State Street Corp ($1.31M), MPM Bioimpact LLC ($1.17M), and Jupiter Topco LLC ($1.07M).

Institutional investors have bought a total of 23,214,634 shares in the last 24 months. This purchase volume represents approximately $439.89M in transactions.

Of the 35 institutional investors that sold Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Versant Venture Management LLC ($2.47M), BVF Inc. IL ($1.82M), Braidwell LP ($755.01K), Alphabet Inc. ($719.07K), Montanova Capital LLC ($677.27K), Baker BROS. Advisors LP ($570.36K), and Marshall Wace LLP ($503.94K).

Institutional investors have sold a total of 9,196,607 shares in the last 24 months. This volume of shares sold represents approximately $152.50M in transactions.

Related Companies

Institutional ownership data for NASDAQ:GLUE is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/21/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Monte Rosa Therapeutics (GLUE) Institutional Ownership

GLUE Institutional Buying and Selling by Quarter

Monte Rosa Therapeutics Major Shareholders & Ownership History

GLUE Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Monte Rosa Therapeutics (GLUE) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Monte Rosa Therapeutics (NASDAQ:GLUE)

GLUE Institutional Buying and Selling by Quarter

Monte Rosa Therapeutics Major Shareholders & Ownership History

GLUE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GLUE shares?

What percentage of Monte Rosa Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Monte Rosa Therapeutics' stock?

How much institutional buying is happening at Monte Rosa Therapeutics?

Which of Monte Rosa Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Monte Rosa Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools